What is PT-141? Learn how bremelanotide works, who the FDA-approved injection is for, side effects, nasal spray questions, and legal status in the US.
PT-141 (bremelanotide) is a synthetic peptide that activates melanocortin receptors in the brain to influence sexual desire. The FDA approved it in June 2019 under the brand name Vyleesi as a subcutaneous injection for premenopausal women with hypoactive sexual desire disorder (HSDD). PT-141 is a prescription medication that works on the nervous system rather than on blood flow, and it does not help everyone who tries it.
If you searched what is pt 141 peptide, you are in the right place. The sections below explain how bremelanotide works, who it is cleared for, how the injection differs from the discontinued nasal spray, and what the safety data actually show.
PT-141 at a Glance
| Fact | Detail |
|---|---|
| Generic name | Bremelanotide |
| Brand name | Vyleesi |
| Drug class | Melanocortin receptor agonist (MC1R, MC3R, MC4R) |
| FDA status | Approved June 2019 for HSDD in premenopausal women |
| Approved form | 1.75 mg subcutaneous autoinjector |
| Timing | Inject at least 45 minutes before anticipated sexual activity |
| Dose limits | No more than one dose in 24 hours, maximum 8 doses per month |
| Most common side effects | Nausea, flushing, headache, injection site reactions |
How PT-141 Works in the Body
PT-141 binds to melanocortin receptors, especially the MC4 receptor in the hypothalamus, which is part of the brain's reward and desire circuitry. That central action is what separates bremelanotide from erectile dysfunction drugs. PT-141 is not a vasodilator in the way sildenafil is.
Viagra and Cialis relax smooth muscle and increase blood flow to the genitals. Those drugs support the physical response but do not create desire. PT-141 is thought to act upstream, on the neurological side of arousal, which is why it is described as a desire treatment rather than a performance drug.
That mechanism also explains the timing. PT-141 does not work within minutes, and it is not taken the way an on-demand ED pill is taken. Measurable effects generally begin about 30 to 60 minutes after injection.
What Is PT-141 Used For?
So what is pt 141 used for in real clinical practice? There is one approved indication and several off-label or investigational ones.
- HSDD in premenopausal women. This is the only FDA-approved use. It applies to women who have persistently low sexual desire that causes personal distress.
- Off-label use in men. Small studies have looked at bremelanotide in men with erectile dysfunction who did not respond well to PDE5 inhibitors. Results have been mixed, and PT-141 is not approved for this use.
- Research on desire disorders. Scientists study the melanocortin system to understand how the brain regulates motivation and arousal.
PT-141 is not approved to treat erectile dysfunction, and it is not approved for postmenopausal women or as a general libido booster.
PT-141 vs. Viagra, Cialis, and Testosterone
These options are often lumped together as libido treatments, but they act on completely different systems in the body.
| Feature | PT-141 (bremelanotide) | PDE5 inhibitors (Viagra, Cialis) | Testosterone therapy |
|---|---|---|---|
| Primary target | Melanocortin receptors in the brain | Blood vessels in the genitals | Androgen receptors throughout the body |
| Main effect | May increase sexual desire | Improves physical arousal and erection | May restore desire when levels are low |
| FDA-approved for | HSDD in premenopausal women | Erectile dysfunction | Hypogonadism |
| Typical form | Subcutaneous injection | Oral tablet | Injection, gel, or pellet |
| Timing | About 45 minutes before activity | 30 to 60 minutes before activity | Ongoing therapy |
| Common side effects | Nausea, flushing, headache | Headache, flushing, nasal congestion | Acne, fluid retention, higher red blood cell count |
A key practical point: PT-141 and PDE5 inhibitors are sometimes discussed together, but PT-141 does not treat the vascular problem that Viagra and Cialis address.
Injection, Nasal Spray, and Research Vials
PT-141 has been studied and sold in more than one form, which creates a lot of confusion about what is actually available in the United States.
- Injection (approved). Most people who search what is pt 141 shots are looking for the injectable version, and the injectable version is the only form with FDA approval. The Vyleesi autoinjector delivers 1.75 mg under the skin of the abdomen or thigh.
- Nasal spray (not approved). The phrase what is pt 141 nasal spray reflects the drug's history. Bremelanotide was first tested as an intranasal spray, but that formulation raised blood pressure and caused other tolerability problems, so development moved to injection. No nasal PT-141 product is FDA approved or stocked in US pharmacies today.
- Research vials (not for human use). Many websites sell lyophilized PT-141 powder labeled "not for human consumption." Those products are not reviewed by the FDA for purity, sterility, or actual peptide content.
Side Effects and Safety
PT-141 is generally tolerated, but the side effect profile is real and it is the main reason some patients stop using it.
- Nausea is the most common complaint and was reported by roughly 40 percent of participants in clinical trials.
- Flushing, headache, and vomiting occur in a smaller share of users.
- Injection site reactions such as pain, bruising, or itching are common with the autoinjector.
- Blood pressure increases are usually small and temporary, but PT-141 is not recommended for people with uncontrolled high blood pressure or known cardiovascular disease.
- Focal hyperpigmentation, or dark patches on the skin, has been reported with repeated use.
PT-141 is not recommended during pregnancy, and it should not be used more than once in a 24-hour period or more than eight times in a month. Anyone considering bremelanotide should review their blood pressure history and current medications with a healthcare professional first.
Is PT-141 Legal in the United States?
PT-141 is legal in the United States with a prescription. Bremelanotide is not a controlled substance, so it is not scheduled like an opioid or a stimulant, but it still requires a licensed prescriber.
Buying PT-141 from a research chemical supplier is a different situation. Those sellers typically state that their products are for laboratory research only, and selling them for human consumption is not permitted. The FDA has issued warnings about unapproved peptide products marketed online, and dosing errors are common when people reconstitute powder at home without sterile technique or accurate measurement.
The Bottom Line
Asking what is pt 141 good for is a fair question, and the honest answer is narrow: it is a prescription option for premenopausal women with low sexual desire that causes distress. For men, nasal spray users, or anyone hoping for a fast-acting pill, PT-141 is either off-label or unavailable in an approved form.
If low desire is affecting your quality of life, a clinician can help sort out whether the cause is hormonal, psychological, medication-related, or something else. PT-141 is one tool among several, and it is not the right fit for everyone.
Frequently Asked Questions
Is PT-141 FDA approved?
Yes, but only for a narrow indication. Bremelanotide was approved in 2019 as Vyleesi for premenopausal women with hypoactive sexual desire disorder. It is not FDA approved for men, for postmenopausal women, or as a nasal spray, so any of those uses would be off-label.
How long does PT-141 take to work, and how often can you use it?
Vyleesi is injected under the skin at least 45 minutes before anticipated sexual activity. Effects typically build over the first hour and can last a few hours. The label limits use to one dose in a 24-hour period and no more than eight doses per month.
Can I buy PT-141 online without a prescription?
PT-141 is prescription-only in the United States, so buying it without a prescription is not legal for human use. Products sold as PT-141 research peptides are labeled not for human consumption and are not reviewed by the FDA for purity, sterility, or actual content. That makes dosing unpredictable and raises the risk of side effects.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.